跳至主要内容
临床试验/JPRN-UMIN000024283
JPRN-UMIN000024283已完成未知

An exploratory clinical trial about the efficacy and safety of GLP-1 receptor agonist dulaglutide in maintenance hemodialysis patients with type 2 diabetes treated with insulin - An exploratory clinical trial about the efficacy and safety of GLP-1 receptor agonist dulaglutide in maintenance hemodialysis patients with type 2 diabetes treated with insulin

iigata University Graduate School of Medical and Dental Sciences Department of Applied Molecular Medicine0 个研究点目标入组 14 人开始时间: 2016年10月11日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
14

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Those with hypersensitivity to DPP-4 inhibitors or GLP-1 receptor agonists 2. Those with serious diabetic ketosis, coma, or pre-coma 3. Those with severe active infection, serious trauma, or in the perioperative period 4. Those with severe heart or liver dysfunction 5. Those with problems shown as below: 1) Pituitary gland or adrenal gland dysfunction 2) In the status of impaired nutrition, starvation, irregular or insufficient dietary intake, or hyposthenia 3) Excessive muscular exercise 4) Heavy alcohol drinkers 6. BMI < 18.5 kg/m2 7. Those who are pregnant or beast-feeding, or those who might be pregnant 8. Those who are considered not eligible for this trial by attending doctors due to any medical reasons

研究者

发起方
iigata University Graduate School of Medical and Dental Sciences Department of Applied Molecular Medicine

相似试验